sglt2 inhibitors vs glp 1 agonists Diabetic Agents, From Metformin to and GLP1 Receptor Agonists: JACC Focus Seminar GLP-1RAs and SGLT2 Inhibitors Show

[DOI] [PubMed] [Google Scholar] 78.Ogunremi OO, Ismail SF, Dhami RK, Newton JS, Kindle SA, Kozmenko V

doi: 10.1016/j.ijcard.2011.09.039 260 McGuireDKShihWJCosentinoFCharbonnelBCherneyDZIDagogo-JackSet al

He has received educational and research grants from GE Healthcare, Novo Nordisk, Piramal Life Science/Life Molecular Imaging, Avid Radiopharmaceuticals, and Eli Lilly

( (Accessed 6/1/2025) What sets apart the adverse events reported with compounded versions is the concern over manufacturing variability and dosing inconsistency, not necessarily a higher number of events, but the increased uncertainty in product quality and composition

SGLT2 stands for Sodium-Glucose Cotransporter 2

Clinical Risks When absorption becomes unpredictable, drug levels can fluctuate